These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17419)

  • 41. Pharmacological studies on perazine and its primary metabolites.
    Brand U; Menge HG; Neumann BW; Stille G
    Pharmacopsychiatry; 1989 Nov; 22(6):255-7. PubMed ID: 2575764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pharmacological experience with phenothiazines and butyrophenones].
    Cuisset P; Roujas F
    Ann Anesthesiol Fr; 1976; 17(9):1025-32. PubMed ID: 13687
    [No Abstract]   [Full Text] [Related]  

  • 43. 10-Alkyl- and 10-aminoalkyl-2,2'-bis(trifluoromethyl)-3,10'-biphenothiazines.
    Nagarajan K; David J; Goud AN
    J Med Chem; 1974 Jun; 17(6):652-3. PubMed ID: 4151457
    [No Abstract]   [Full Text] [Related]  

  • 44. Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: evidence for two different mechanisms of action.
    Ljungberg T; Ungerstedt U
    Psychopharmacology (Berl); 1978 Apr; 56(3):239-47. PubMed ID: 26097
    [No Abstract]   [Full Text] [Related]  

  • 45. Psychotropic agents. 3. 4-(4-Substituted piperidinyl)-1-(4-fluorophenyl)-1-butanones with potent neuroleptic activity.
    Sato M; Arimoto M; Ueno K; Kojima H; Yamasaki T; Sakurai T; Kasahara A
    J Med Chem; 1978 Nov; 21(11):1116-20. PubMed ID: 31476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of chronic administration of neuroleptics: dyskinesias in monkeys.
    Paulson G
    Pharmacol Ther B; 1976; 2(1):167-71. PubMed ID: 4829
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of chlorpromazine and other anti-psychotic drugs on mouse striatal tyramines.
    Juorio AV
    Life Sci; 1977 May; 20(10):1663-7. PubMed ID: 17797
    [No Abstract]   [Full Text] [Related]  

  • 48. Antiapomorphine and locomotor effects of neuroleptics in rhesus monkeys.
    Porsolt RD; Roux S; Jalfre M
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1309-12. PubMed ID: 6131438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Behavioral evidence for dopaminergic supersensitivity following chronic treatment with methadone or chlorpromazine in the guinea pig.
    Eibergen RD; Carlson KR
    Psychopharmacology (Berl); 1976 Jul; 48(2):139-46. PubMed ID: 826925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals.
    Hardman HF; Haavik CO; Seevers MH
    Toxicol Appl Pharmacol; 1973 Jun; 25(2):299-309. PubMed ID: 4197635
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacological studies with a tripeptide, prolyl-leucyl glycine amide.
    Plotnikoff NP; Kastin AJ
    Arch Int Pharmacodyn Ther; 1974 Oct; 211(2):211-24. PubMed ID: 4156639
    [No Abstract]   [Full Text] [Related]  

  • 52. Synthesis of 3-phenyl-3-phenylthiopropionic acids, amides, amines and studies on their pharmacological properties.
    Mirek J; Chojnacka-Wójcik E; Tatarzyńska E; Wiczyńska B
    Farmaco Sci; 1985 Sep; 40(9):701-8. PubMed ID: 4076432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BW 234U, (cis-9-[3-(3,5-dimethyl-1-piperazinyl)propyl]carbazole dihydrochloride): a novel antipsychotic agent.
    Ferris RM; Harfenist M; McKenzie GM; Cooper B; Soroko FE; Maxwell RA
    J Pharm Pharmacol; 1982 Jun; 34(6):388-90. PubMed ID: 6124624
    [No Abstract]   [Full Text] [Related]  

  • 54. Behavioral, autonomic and motor effects of neuroleptic drugs in cats: motor impairment and aggression.
    Beleslin DB; Jovanović-Mićić D; Japundzić N; Terzić AM; Samardzić R
    Brain Res Bull; 1985 Sep; 15(3):353-6. PubMed ID: 2864989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of chlorprothixene, haloperidol, and trifluoperazine on the delayed-matching-to-sample performance of pigeons.
    Poling A; Picker M; Thomas J
    Pharmacol Biochem Behav; 1984 Nov; 21(5):721-6. PubMed ID: 6151195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antagonism of reserpine rigidity without inducing sedation.
    Southwick S; Anderson RJ
    Psychopharmacology (Berl); 1981; 74(1):29-32. PubMed ID: 6115441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological study of pipotiazine (19.366 R.P.) and its undecylenic (19.551 R.P.) and palmitic (19.552 R.P.) esters.
    Julou L; Bourat G; Ducrot R; Fournel J; Garret C
    Acta Psychiatr Scand Suppl; 1973; 241():9-30. PubMed ID: 4147517
    [No Abstract]   [Full Text] [Related]  

  • 58. 3-Aminotetrahydrocarbazoles as a new series of central nervous system agents.
    Mooradian A; Dupont PE; Hlavec AG; Aceto MD; Pearl J
    J Med Chem; 1977 Apr; 20(4):487-92. PubMed ID: 403284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological properties of tetrahydronorharmane (tryptoline).
    Rommelspacher H; Kauffmann H; Cohnitz CH; Coper H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jun; 298(2):83-91. PubMed ID: 560635
    [No Abstract]   [Full Text] [Related]  

  • 60. [Synthesis of metabolites of mosapramine. II. Synthesis of phenolic metabolites of mosapramine and their pharmacological activities].
    Tashiro C; Yuasa S; Fukuda T
    Yakugaku Zasshi; 1992 Sep; 112(9):615-21. PubMed ID: 1361567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.